Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Fetal valproate syndrome


Other Names for this Disease
  • Valproic acid fetal effects from
  • Embryofoetal valproic acid syndrome
  • Valproic acid embryopathy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might fetal valproate syndrome be treated?

Currently there are no specific treatments for fetal valproate syndrome. Each symptom or birth defect associated with fetal valproate syndrome are managed individually, and may require a team of specialist.  To read about different types of specialists and what they do, you can visit the following link to Harvard Medical School’s Family Health Guide:
http://www.health.harvard.edu/fhg/specialists.shtml 

In general, children with fetal valproate syndrome who show delays in comprehension and expression of speech, may be benefited by early speech therapy.[1] Physiotherapy may benefit children with motor delays.[1] Also some children with fetal valproate syndrome may require extra help in school.[1] The following resource may be helpful for families with a child with developmental, learning, or behavioral issues.

National Dissemination Center for Children with Disabilities
P.O. Box 1492
Washington, DC 20013
Toll free/TTY: (800) 695-0285
Fax: (202) 884-8441
E-mail: nichcy@aed.org
Web site: http://www.nichcy.org
Last updated: 3/5/2010

References
  1. Kini U. Fetal valproate syndrome: a review. Paediatric and Perinatal Drug Therapy. 2006;


GARD Video Tutorial

  • Finding Treatment Information - A video developed by GARD Information Specialists that explains how you can find information about treatment for a rare disease.

    Finding Treatment Information

Management Guidelines

  • The National Guideline Clearinghouse (NGC) has information on the use of psychiatric medications during pregnancy and lactation, including guidelines regarding the use of valproic acid. The NGC is a public resource for evidence-based clinical practice guidelines. The NGC was originally created by the Agency for Healthcare Research and Quality (AHRQ) in partnership with the American Medical Association and the American Association of Health Plans.

Clinical Trials & Research for this Disease

  • The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  There is a study titled "Washington obstetric-fetal  pharmacology research unit" that may be of interest to you. Click on the link above to learn more about this study.
Other Names for this Disease
  • Valproic acid fetal effects from
  • Embryofoetal valproic acid syndrome
  • Valproic acid embryopathy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.